Paramount Pictures has offered concessions to the EU in a high-profile probe into the film licensing practices of the six Hollywood studios in Europe.
Representatives of the European film industry have sharply criticized Viacom’s Paramount Pictures for offering concessions to European regulators in an ongoing antitrust case involving all six major Hollywood studios.
Paramount last week became the first studio to offer the European Union a deal in exchange for the European Commission dropping the probe into the studios’ European film licensing deals.
But Alfred Holighaus, president of German film industry body SPIO, slammed the deal as a threat to the European film industry.
The Commission filed an antitrust complaint last summer, accusing Paramount, Disney, NBCUniversal, Sony, 20th Century Fox and Warner of illegally restricting customers’ access to content within the European Union in their licensing deals with Sky UK, part of pan-European pay TV giant Sky. 21st Century Fox owns a 39 percent stake in Sky.
Paramount’s offer to the Commission would see the studio agree to allow Sky UK to sell its licensed Paramount films to customers from outside the U.K. and to let pay TV companies outside Britain, which have deals with Paramount, to offer their films to UK customers.
In essence, it would break down territorial boundaries between European countries, something the Commission is pushing for as part of its strategy to create a digital single market across Europe by 2017.
Full Content: Hollywood Reporter
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas